BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 14699405)

  • 1. Human primary immunodeficiency diseases: a perspective.
    Fischer A
    Nat Immunol; 2004 Jan; 5(1):23-30. PubMed ID: 14699405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA targets of AID evolutionary link between antibody somatic hypermutation and class switch recombination.
    Hackney JA; Misaghi S; Senger K; Garris C; Sun Y; Lorenzo MN; Zarrin AA
    Adv Immunol; 2009; 101():163-89. PubMed ID: 19231595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A primary immunodeficiency characterized by defective immunoglobulin class switch recombination and impaired DNA repair.
    Péron S; Pan-Hammarström Q; Imai K; Du L; Taubenheim N; Sanal O; Marodi L; Bergelin-Besançon A; Benkerrou M; de Villartay JP; Fischer A; Revy P; Durandy A
    J Exp Med; 2007 May; 204(5):1207-16. PubMed ID: 17485519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunodeficiencies with autoimmune consequences.
    Notarangelo LD; Gambineri E; Badolato R
    Adv Immunol; 2006; 89():321-70. PubMed ID: 16682278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of activation-induced cytidine deaminase in antibody diversification, immunodeficiency, and B-cell malignancies.
    Luo Z; Ronai D; Scharff MD
    J Allergy Clin Immunol; 2004 Oct; 114(4):726-35; quiz 736. PubMed ID: 15480307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defects of class-switch recombination.
    Notarangelo LD; Lanzi G; Peron S; Durandy A
    J Allergy Clin Immunol; 2006 Apr; 117(4):855-64. PubMed ID: 16630945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation-induced cytidine deaminase: structure-function relationship as based on the study of mutants.
    Durandy A; Peron S; Taubenheim N; Fischer A
    Hum Mutat; 2006 Dec; 27(12):1185-91. PubMed ID: 16964591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Separate domains of AID are required for somatic hypermutation and class-switch recombination.
    Shinkura R; Ito S; Begum NA; Nagaoka H; Muramatsu M; Kinoshita K; Sakakibara Y; Hijikata H; Honjo T
    Nat Immunol; 2004 Jul; 5(7):707-12. PubMed ID: 15195091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoglobulin class switch recombination deficiencies.
    Kracker S; Gardes P; Mazerolles F; Durandy A
    Clin Immunol; 2010 May; 135(2):193-203. PubMed ID: 20167540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in AID and UNG extend the function of AID.
    Li Z; Woo CJ; Scharff MD
    Nat Immunol; 2003 Oct; 4(10):945-6. PubMed ID: 14515126
    [No Abstract]   [Full Text] [Related]  

  • 11. Regulating antibody diversity: taming a mutagen.
    Gearhart PJ; Sen R
    Mol Cell; 2008 Sep; 31(5):615-6. PubMed ID: 18775319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological and genetic bases of new primary immunodeficiencies.
    Maródi L; Notarangelo LD
    Nat Rev Immunol; 2007 Nov; 7(11):851-61. PubMed ID: 17960151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary immunodeficiencies: a field in its infancy.
    Casanova JL; Abel L
    Science; 2007 Aug; 317(5838):617-9. PubMed ID: 17673650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative regulation of activation-induced cytidine deaminase in B cells.
    Muto T; Okazaki IM; Yamada S; Tanaka Y; Kinoshita K; Muramatsu M; Nagaoka H; Honjo T
    Proc Natl Acad Sci U S A; 2006 Feb; 103(8):2752-7. PubMed ID: 16477013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody diversity: one enzyme to rule them all.
    Nussenzweig MC; Alt FW
    Nat Med; 2004 Dec; 10(12):1304-5. PubMed ID: 15580255
    [No Abstract]   [Full Text] [Related]  

  • 16. From infectious diseases to primary immunodeficiencies.
    Bustamante J; Zhang SY; von Bernuth H; Abel L; Casanova JL
    Immunol Allergy Clin North Am; 2008 May; 28(2):235-58, vii. PubMed ID: 18424331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA deamination in immunity.
    Petersen-Mahrt S
    Immunol Rev; 2005 Feb; 203():80-97. PubMed ID: 15661023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential roles of activation-induced cytidine deaminase in promotion or prevention of autoimmunity in humans.
    Durandy A; Cantaert T; Kracker S; Meffre E
    Autoimmunity; 2013 Mar; 46(2):148-56. PubMed ID: 23215867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to Activation-Induced Cytidine Deaminase deficiency.
    Quartier P; Bustamante J; Sanal O; Plebani A; Debré M; Deville A; Litzman J; Levy J; Fermand JP; Lane P; Horneff G; Aksu G; Yalçin I; Davies G; Tezcan I; Ersoy F; Catalan N; Imai K; Fischer A; Durandy A
    Clin Immunol; 2004 Jan; 110(1):22-9. PubMed ID: 14962793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune dysregulation in primary immunodeficiency disorders.
    Torgerson TR
    Immunol Allergy Clin North Am; 2008 May; 28(2):315-27, viii-ix. PubMed ID: 18424335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.